← Back to Analyst Consensus 
GMED Buy
GLOBUS MEDICAL INC
Current Price —
Implied Upside —
Analysts 23
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 28, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Jul 16, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Jul 13, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 9, 2026 | BMO Capital | initiate | — → Outperform | — | 53% |
| Jul 8, 2026 | Stifel | maintain | Hold → Hold | — | 54% |
| Jun 15, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 8, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Feb 26, 2026 | Wells Fargo | maintain | Overweight → Overweight | $104 | 54% |
| Feb 25, 2026 | Barclays | maintain | Overweight → Overweight | $123 | 53% |
| Feb 25, 2026 | Needham | maintain | Buy → Buy | $114 | 50% |
| Jan 30, 2026 | Needham | upgrade | Hold → Buy | $112 | 50% |
| Jan 9, 2026 | Canaccord Genuity | maintain | Buy → Buy | $112 | 48% |
| Jan 8, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $115 | 54% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Buy → Buy | $105 | 48% |
| Dec 17, 2025 | RBC Capital | maintain | Outperform → Outperform | $100 | 55% |
| Dec 17, 2025 | Freedom Capital Markets | initiate | — → Hold | $87 | 43% |
| Dec 2, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $100 | 54% |
| Nov 18, 2025 | Truist Securities | reiterate | Buy → Buy | $105 | 55% |
| Nov 10, 2025 | Barclays | maintain | Overweight → Overweight | $114 | 53% |
| Nov 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $92 | 55% |
| Nov 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $79 | 54% |
| Nov 7, 2025 | B of A Securities | upgrade | Neutral → Buy | $91 | 53% |
| Nov 7, 2025 | Truist Securities | upgrade | Hold → Buy | $93 | 55% |
| Oct 10, 2025 | RBC Capital | maintain | Outperform → Outperform | $88 | 55% |
| Aug 8, 2025 | Wells Fargo | maintain | Overweight → Overweight | $66 | 54% |
| Jul 22, 2025 | Canaccord Genuity | maintain | Buy → Buy | $90 | 48% |
| Jul 21, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jul 15, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $68 | 54% |
| May 27, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| May 27, 2025 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| May 12, 2025 | Truist Securities | maintain | Hold → Hold | $68 | 55% |
| May 9, 2025 | Piper Sandler | maintain | Overweight → Overweight | $80 | 54% |
| May 9, 2025 | BTIG | maintain | Buy → Buy | $77 | 52% |
| Apr 11, 2025 | Truist Securities | maintain | Hold → Hold | $80 | 55% |
| Apr 9, 2025 | BTIG | maintain | Buy → Buy | $88 | 52% |
| Mar 18, 2025 | Truist Securities | maintain | Hold → Hold | $82 | 55% |
| Mar 18, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Feb 24, 2025 | Citizens Capital Markets | reiterate | Market Perform → Market Perform | $0 | 49% |
| Feb 24, 2025 | Barclays | maintain | Overweight → Overweight | $103 | 53% |
| Feb 21, 2025 | Stifel | maintain | Buy → Buy | $94 | 54% |
| Feb 21, 2025 | Wells Fargo | maintain | Overweight → Overweight | $93 | 54% |
| Feb 21, 2025 | BTIG | maintain | Buy → Buy | $94 | 52% |
| Feb 21, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Feb 6, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Jan 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $101 | 48% |
| Jan 9, 2025 | B of A Securities | upgrade | Underperform → Neutral | $97 | 53% |
Price Target Trend
Jul 2, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days